Filing Details
- Accession Number:
- 0001209191-22-045447
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-11 17:00:28
- Reporting Period:
- 2022-08-10
- Accepted Time:
- 2022-08-11 17:00:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840574 | Verve Therapeutics Inc. | VERV | Pharmaceutical Preparations (2834) | 824800132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864112 | Sekar Kathiresan | C/O Verve Therapeutics 500 Technology Square, Suite 901 Cambridge MA 02139 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-10 | 50,000 | $1.39 | 367,839 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-10 | 50,000 | $29.90 | 317,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-10 | 50,000 | $0.00 | 50,000 | $1.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 167,425 | 2029-04-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 240,997 | Indirect | Kathiresan Family 2021 Irrevocable Trust |
| Common Stock | 80,997 | Indirect | Sekar Kathiresan 2021 Irrevocable Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 21, 2022.
- The remaining shares underlying this option, which was granted on April 15, 2019 and commenced vesting on July 22, 2019, vest in equal monthly installments thereafter until July 22, 2023.
Billionaire Hedge Funds
